key: cord-0835440-01ku1yti authors: Ho, Josephine; Rosolowsky, Elizabeth; Pacaud, Daniele; Huang, Carol; Lemay, Julie‐Anne; Brockman, Nicole; Rath, Mitchell; Doulla, Manpreet title: Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID‐19 pandemic date: 2021-03-27 journal: Pediatr Diabetes DOI: 10.1111/pedi.13205 sha: 999fa01933f6ae11100ebcb34f66a178d48ad2d2 doc_id: 835440 cord_uid: 01ku1yti OBJECTIVE: The COVID‐19 pandemic has led to significant public health measures that have resulted in decreased acute pediatric care utilization. We evaluated whether the rate of severe presentations of new onset type 1 diabetes (DM1), such as, diabetic ketoacidosis (DKA) has changed since the COVID‐19 public health measures were enacted. RESEARCH DESIGN AND METHODS: A retrospective chart review of children less than 18 years of age presenting with new onset DM1 during the pandemic period of March 17, 2020 to August 31, 2020 was conducted at two tertiary care pediatric hospitals in Alberta, Canada. Rates of DKA and severe DKA were compared to the same time period in the year 2019 (pre‐pandemic control). RESULTS: The number of children presenting with newly diagnosed DM1 was similar during the pandemic year of 2020 compared with 2019 (107 children in 2020 vs. 114 in 2019). The frequency of DKA at DM1 onset was significantly higher in the pandemic period (68.2% vs 45.6%; p < 0.001) and incidence of severe DKA was also higher (27.1% in 2020 vs 13.2% in 2019; p = 0.01). CONCLUSIONS: There was a significant increase in DKA and severe DKA in children presenting with new onset DM1 during the COVID‐19 pandemic period. This emphasizes the need for educating health care professionals and families to be aware of the symptoms of hyperglycemia and the importance of early diagnosis and treatment even during public health measures for COVID‐19. The SARS-Coronavirus-2 pandemic (COVID-19) is a serious health crisis with severe morbidity and mortality worldwide. was labeled a global pandemic by the World Health Organization on March 11, 2020 with a call for countries to make crucial and timely changes to control global virus transmission and prevent overburdening of the healthcare system. 1 Diabetic ketoacidosis (DKA) is a potentially severe, lifethreatening presentation of diabetes that can lead to significant morbidity in children; it is also largely preventable. The prevalence of ketoacidosis at diabetes diagnosis in children between the years 2008 and 2017 in the United States has increased from 31% to 58%, respectively. 5, 6 Canadian data suggest recent prevalence rates of 18 .6% to 25.6%. 7, 8 Healthcare provider perceptions suggest a delay in diagnosis of children with new onset DM1 during the COVID-19 pandemic due to possible fears around virus transmission during healthcare appointments and under-recognition of symptoms secondary to reduced face-to-face interactions with medical providers. 9 Recent evidence has emerged showing an increase in severe ketoacidosis at diabetes diagnosis in children in Germany, Italy, and Australia. [10] [11] [12] We hypothesized that the COVID-19 pandemic would have an effect on the rate of severe presentations of new onset type 1 diabetes (DM1), such as, DKA. We report the frequency of DKA presentations at onset of type 1 diabetes diagnosis in the pediatric population in Alberta, Canada during the COVID-19 pandemic compared to pre-pandemic control rates in 2019. The study design was a multi-center, retrospective chart review. The study population included children less than 18 The incidence of DKA at DM1 onset before and during COVID-19 public health restrictions was reported. Means, medians and interquartile ranges were used to describe age at diagnosis and duration of symptoms. The difference in incidence rate of DM1 diagnosis between 2019 and 2020 periods was calculated with the chi-square approximation for incidence rates using child population data from the Government of Alberta. 16 Additional comparisons, such as, the severity of DKA, were analyzed using the chi-square test or Fisher's exact test where the assumptions of the chi-square test are not met. A p-value of <0.05 was used to determine statistical significance. Statistical analysis completed using the R Version 3.5.2 (R Core Team, 2018). During the COVID-19 pandemic, initial presentations of DM1 were more severe, likely due to the pandemic's impact on the healthcare system and health delivery. There was no increase in incidence of DM1 in children during the pandemic; however, there was a significant increase in rates of DKA. Early recognition of clinical signs and symptoms of DM1 by healthcare providers and families can lead to rapid initiation of effective outpatient stabilization and treatment. We stress the importance of timely access to healthcare and immediate referral to pediatric diabetes services or an emergency department upon recognition of the symptoms of DM1. When the diagnosis of DM1 is delayed, as we have seen during the COVID-19 pandemic, individuals will continue to have rapid metabolic decompensation, resulting in DKA. DKA is associated with morbidity and mortality, and our data supports the need for targeted awareness campaigns aimed at preventing DKA at DM1 diagnosis through early symptom recognition and early treatment. No funding was received in association with this manuscript World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19-11 Government of Alberta. COVID-19 orders and legislation Mar 16 Where have all the children gone? Decreases in paediatric emergency department attendances at the start of the COVID-19 pandemic of 2020 Addressing the indirect effects of COVID-19 on the health of children and young people Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study Diabetic ketoacidosis at diagnosis of type 1 diabetes in Colorado children Increasing prevalence of diabetic ketoacidosis at diabetes diagnosis among children in Quebec: a population-based retrospective cohort study Is diabetic ketoacidosis at disease onset a result of missed diagnosis? COVID-19 outbreak and pediatric diabetes: perceptions of health care professionals worldwide Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany Diabetes study Group of the Italian Society for pediatric E, et al. has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary Centre during the COVID-19 pandemic Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome Diabetes Canada Clinical Practice Guidelines Expert C ISPAD Clinical Practice Consensus Guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state Government of Alberta Treasury Board and Finance. Annual Population Report Did the COVID-19 lockdown affect the incidence of pediatric type 1 diabetes in Germany? Diabetes Care New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care Delayed access or provision of care in Italy resulting from fear of COVID-19 Preventing diabetic ketoacidosis Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor long-term glycemic control Type 1 diabetes incidence and prevalence trends in a cohort of Canadian children and youth Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices A diabetes awareness campaign prevents diabetic ketoacidosis in children at their initial presentation with type 1 diabetes Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic The authors declare no potential conflict of interest. The peer review history for this article is available at https://publons. com/publon/10.1111/pedi.13205. The authors are unable to share the data repository as it would compromise the ethical standards and legal requirements. https://orcid.org/0000-0003-0379-4427Elizabeth Rosolowsky https://orcid.org/0000-0002-0402-4240Daniele Pacaud https://orcid.org/0000-0001-6337-7241Manpreet Doulla https://orcid.org/0000-0001-5574-7863